4,4'-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile-D4; 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bisbenzonitrile-d4; 4-[1-(4-Cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile-d4; CGS 20267-d4; Femara-d4; Lerozole-d4; Letrazole-d4
Letrozole-d4 is a fully characterized chemical compound used as a reference standard of API Letrozole. The standard offered is compliant with regulatory guidelines. Letrozole-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1133712-96-5
